Gilead, BioMarin among Bay Area drug makers shamed by FDA in generics 'gaming' list
May 17, 2018 at 16:13 PM EDT
Opening another front in President Donald Trump's war on drug prices, the FDA releases a list of companies "gaming" the system to delay lower-priced generics from getting to market.
